Myomar Molecular Closes $3.5M Round
Halifax-based Myomar Molecular, which has developed a urine test that assesses muscle health, has closed a $3.5 million seed round that will help it expand into the U.S. and Asia.
In an interview, Co-Founder and CEO Rafaela Andrade said the round comprised $1.6 million in equity investment, led by the Northern Ontario Angels, and $1.9 million in non-dilutive funding. The organizations